Toshifumi Iida
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Toshifumi Iida has a total of 42 co-authors. Here are the top co-authors by number of shared publications:
- Hideyuki Chiba
Department of Gastroenterology, Omori Red Cross Hospital, Tokyo, Japan
5 shared publications - Ken Ohata
Department of Gastrointestinal Endoscopy, NTT Medical Center Tokyo, Shinagawa-ku, Japan
4 shared publications Yohei Minato
Department of Gastrointestinal Endoscopy NTT Medical Center Tokyo Tokyo Japan
3 shared publicationsAi Hirohata
Department of Gastroenterology, Omori Red Cross Hospital, Tokyo, Japan
2 shared publicationsAkimichi Hayashi
Department of Gastroenterology, Omori Red Cross Hospital, Tokyo, Japan
2 shared publicationsEtsuko Yamabe
Department of Gastrointestinal Endoscopy NTT Medical Center Tokyo Tokyo Japan
2 shared publications
Latest Publications
- Open Access
Prepackaged Low‐Residue Diet “Clear‐Through” Reduces the Required Volume of Polyethylene Glycol Solution for Colonoscopy Preparation: An Exploratory Randomized Controlled Study
Objectives: Large volumes of polyethylene glycol (PEG) solution reduce patient acceptance of colonoscopy. A prepackaged low‐residue diet (PLRD; Clear‐Through) may improve bowel cleansing and allow further PEG reduction. This exploratory randomized study evaluated whether PLRD permits decreased PEG with ascorbic acid (PEG‐Asc) volume while maintaining cleansing quality. Methods: In this single‐center, endoscopist‐blinded, three‐arm randomized trial, 180 patients were allocated to Group A (self‐adjusted diet + 1.5 L PEG‐Asc), Group B (PLRD + 1.5 L PEG‐Asc), or Group C (PLRD + 1.0 L PEG‐Asc). The primary endpoint was cleansing quality using the Ottawa Bowel Preparation Score (OBPS). Secondary endpoints included bubble score, bowel movement frequency, adherence, tolerability, patient satisfaction compared with the previous colonoscopy, and adverse events. Logistic regression identified predictors of inadequate cleansing. Results: Baseline characteristics were comparable across groups. OBPS didn't differ significantly among the groups. Group C had significantly fewer bowel movements ( p < 0.001) and a lower bubble score ( p < 0.001). Adherence and tolerability were high, with no major adverse events. Reduced‐volume preparation didn't negatively affect patient satisfaction; Group C had the highest proportion rating the preparation better than their previous experience (42.9%; p = 0.019). PLRD intake independently reduced the risk of inadequate right‐colon cleansing (odds ratio 0.119; 95% confidence interval 0.043–0.327; p < 0.001). Conclusions: PLRD allowed reduction of PEG‐Asc to 1.0 L without impairing cleansing quality, while maintaining favorable patient satisfaction. PLRD may serve as a practical strategy to lessen patient burden during colonoscopy preparation. Trial Registration: UMIN 000056459.
Open AccessPrepackaged Low‐Residue Diet “Clear‐Through” Reduces the Required Volume of Polyethylene Glycol Solution for Colonoscopy Preparation: An Exploratory Randomized Controlled Study
Objectives: Large volumes of polyethylene glycol (PEG) solution reduce patient acceptance of colonoscopy. A prepackaged low‐residue diet (PLRD; Clear‐Through) may improve bowel cleansing and allow further PEG reduction. This exploratory randomized study evaluated whether PLRD permits decreased PEG with ascorbic acid (PEG‐Asc) volume while maintaining cleansing quality. Methods: In this single‐center, endoscopist‐blinded, three‐arm randomized trial, 180 patients were allocated to Group A (self‐adjusted diet + 1.5 L PEG‐Asc), Group B (PLRD + 1.5 L PEG‐Asc), or Group C (PLRD + 1.0 L PEG‐Asc). The primary endpoint was cleansing quality using the Ottawa Bowel Preparation Score (OBPS). Secondary endpoints included bubble score, bowel movement frequency, adherence, tolerability, patient satisfaction compared with the previous colonoscopy, and adverse events. Logistic regression identified predictors of inadequate cleansing. Results: Baseline characteristics were comparable across groups. OBPS didn't differ significantly among the groups. Group C had significantly fewer bowel movements ( p < 0.001) and a lower bubble score ( p < 0.001). Adherence and tolerability were high, with no major adverse events. Reduced‐volume preparation didn't negatively affect patient satisfaction; Group C had the highest proportion rating the preparation better than their previous experience (42.9%; p = 0.019). PLRD intake independently reduced the risk of inadequate right‐colon cleansing (odds ratio 0.119; 95% confidence interval 0.043–0.327; p < 0.001). Conclusions: PLRD allowed reduction of PEG‐Asc to 1.0 L without impairing cleansing quality, while maintaining favorable patient satisfaction. PLRD may serve as a practical strategy to lessen patient burden during colonoscopy preparation. Trial Registration: UMIN 000056459.
- Open Access
- 13 January 2026
- Published by Georg Thieme Verlag KG in Endoscopy International Open
- Vol. 14 (CP)
Second lesions located within the same belt-like region along the stomach's short axis as primary lesions: Boundary equal lesion trends
Gastric adenoma and cancer are common in Asia, with early detection critical for prognosis. Synchronous multiple early gastric cancers (SMEGCs) occur in 6% to 14% of cases, but their clinicopathological characteristics remain unclear. This study analyzed synchronous multiple gastric neoplasms treated by endoscopic resection or surgery to aid early detection. Among 2,991 cases of early gastric cancer or adenoma diagnosed at our institution, 173 patients with 346 synchronous lesions (January 2016-March 2024) were analyzed. All lesions were mucosal or submucosal. Lesions were categorized as “1st” (larger) and “2nd” (smaller), and clinicopathological characteristics were compared using Chi-square and Fisher’s exact tests with Cramér’s V. Patients had a mean age of 73.2 years; 72.8% were male. Most lesions were in the lower/middle stomach, differentiated (92.2%), depressed (52.9%), and brownish on narrow-band imaging (65.3%). Mean tumor diameter was 13.4 mm. Although 1st lesions were larger, other features showed high concordance (≥ 0.25 Cramér’s V) in location, morphology, histology, invasion depth, and coloration. Survival was 94.8% (nine unrelated deaths). Synchronous multiple gastric neoplasms tend to have similar endoscopic and histopathologic features and often occur within the same belt-like region along the short axis of the stomach. This pattern was named boundary equal lesions trends (BELT). When detecting one lesion, considering BELT is essential.
- 13 January 2026
- Published by Georg Thieme Verlag KG in Endoscopy International Open
- Vol. 14 (CP)
Open AccessSecond lesions located within the same belt-like region along the stomach's short axis as primary lesions: Boundary equal lesion trends
Gastric adenoma and cancer are common in Asia, with early detection critical for prognosis. Synchronous multiple early gastric cancers (SMEGCs) occur in 6% to 14% of cases, but their clinicopathological characteristics remain unclear. This study analyzed synchronous multiple gastric neoplasms treated by endoscopic resection or surgery to aid early detection. Among 2,991 cases of early gastric cancer or adenoma diagnosed at our institution, 173 patients with 346 synchronous lesions (January 2016-March 2024) were analyzed. All lesions were mucosal or submucosal. Lesions were categorized as “1st” (larger) and “2nd” (smaller), and clinicopathological characteristics were compared using Chi-square and Fisher’s exact tests with Cramér’s V. Patients had a mean age of 73.2 years; 72.8% were male. Most lesions were in the lower/middle stomach, differentiated (92.2%), depressed (52.9%), and brownish on narrow-band imaging (65.3%). Mean tumor diameter was 13.4 mm. Although 1st lesions were larger, other features showed high concordance (≥ 0.25 Cramér’s V) in location, morphology, histology, invasion depth, and coloration. Survival was 94.8% (nine unrelated deaths). Synchronous multiple gastric neoplasms tend to have similar endoscopic and histopathologic features and often occur within the same belt-like region along the short axis of the stomach. This pattern was named boundary equal lesions trends (BELT). When detecting one lesion, considering BELT is essential.
- Open Access
- 8 January 2026
- Published by Georg Thieme Verlag KG in Endoscopy
- Vol. 58 (S 01) , E192-E193
Endoscopic submucosal dissection with a traction-guided rendezvous approach for sigmoid colon cancer in the distal limb of a double-barrel colostomy
- 8 January 2026
- Published by Georg Thieme Verlag KG in Endoscopy
- Vol. 58 (S 01) , E192-E193
Open AccessEndoscopic submucosal dissection with a traction-guided rendezvous approach for sigmoid colon cancer in the distal limb of a double-barrel colostomy
- Open Access
- 30 September 2025
- Published by The Korean Society of Gastrointestinal Endoscopy in Clinical Endoscopy
- Vol. 58 (5) , 712-721
Efficacy and safety of endoscopic submucosal dissection versus endoscopic papillectomy for managing laterally spreading duodenal papillary tumors
Background/Aim: Endoscopic submucosal dissection (ESD) can be performed to treat laterally spreading duodenal papillary tumors (LSPTs). However, no studies have been conducted on the outcomes of ESDs for LSPTs.Methods: We retrospectively compared 47 patients who underwent endoscopic papillectomies (EPs) for papillary tumors (PTs) between June 2007 and July 2023 (EP group) and eight patients who underwent ESDs for LSPTs between February 2022 and July 2023 (ESD group). In the subgroup analysis, five patients who underwent EPs for LSPTs were compared with eight patients who underwent ESDs for LSPTs.Results: Procedure times and tumor diameters were significantly greater in the ESD group than in the EP group. The positive or unclear vertical margin (VM1/X) rate was significantly higher in the ESD group. Additional therapies were administered for patients with VM1/X in the ESD group, and no local recurrence was observed. No delayed adverse events occurred in the ESD group; however, delayed bleeding and perforation occurred in the EP group. In the subgroup analysis, the en bloc resection rate was significantly higher in the ESD group than in the EP group. The VM1/X rate did not differ significantly between groups.Conclusions: We suggest that ESD is both feasible and safe for LSPTs.
- 30 September 2025
- Published by The Korean Society of Gastrointestinal Endoscopy in Clinical Endoscopy
- Vol. 58 (5) , 712-721
Open AccessEfficacy and safety of endoscopic submucosal dissection versus endoscopic papillectomy for managing laterally spreading duodenal papillary tumors
Background/Aim: Endoscopic submucosal dissection (ESD) can be performed to treat laterally spreading duodenal papillary tumors (LSPTs). However, no studies have been conducted on the outcomes of ESDs for LSPTs.Methods: We retrospectively compared 47 patients who underwent endoscopic papillectomies (EPs) for papillary tumors (PTs) between June 2007 and July 2023 (EP group) and eight patients who underwent ESDs for LSPTs between February 2022 and July 2023 (ESD group). In the subgroup analysis, five patients who underwent EPs for LSPTs were compared with eight patients who underwent ESDs for LSPTs.Results: Procedure times and tumor diameters were significantly greater in the ESD group than in the EP group. The positive or unclear vertical margin (VM1/X) rate was significantly higher in the ESD group. Additional therapies were administered for patients with VM1/X in the ESD group, and no local recurrence was observed. No delayed adverse events occurred in the ESD group; however, delayed bleeding and perforation occurred in the EP group. In the subgroup analysis, the en bloc resection rate was significantly higher in the ESD group than in the EP group. The VM1/X rate did not differ significantly between groups.Conclusions: We suggest that ESD is both feasible and safe for LSPTs.
- Open Access
Electrolyte Depletion Syndrome due to a 28 cm Rectal Villous Tumor: Successful Endoscopic Resection of One of the Largest Tumors Reported to Date—A Case Report
Electrolyte depletion syndrome (EDS), also known as McKittrick–Wheelock syndrome, is a rare but life‐threatening condition caused by secretory diarrhea from colorectal villous tumors, often accompanied by severe electrolyte imbalances and renal dysfunction. Large, circumferential tumors have traditionally been managed with surgical resection, frequently requiring stoma formation. Recently, endoscopic submucosal dissection (ESD) has emerged as a minimally invasive alternative, although its feasibility for large rectal tumors remains limited. We report a case of EDS caused by a giant circumferential rectal villous tumor measuring approximately 28 cm, successfully treated with ESD. A 58‐year‐old man presented with persistent diarrhea, electrolyte disturbances, and acute kidney injury. Imaging and endoscopy revealed a circumferential villous tumor extending from the anal verge to the rectosigmoid colon, diagnosed as a villous adenoma without malignancy on biopsy. After careful discussion between the departments of gastrointestinal surgery and gastroenterology, ESD under general anesthesia was selected to avoid colectomy and stoma creation. En bloc resection of a 280 × 240 mm tumor was achieved without major complications. Prophylactic steroid injection and systemic steroid administration prevented post‐ESD stricture. Histopathology revealed adenocarcinoma with minimal submucosal invasion (800 µm), no lymphovascular invasion, and negative resection margins, indicating curative resection. At 6‐month follow‐up, no recurrence or stricture was observed. This case highlights the potential of ESD as a definitive and less invasive treatment option for EDS caused by large rectal villous tumors when performed with appropriate therapeutic planning and meticulous postoperative care.
Open AccessElectrolyte Depletion Syndrome due to a 28 cm Rectal Villous Tumor: Successful Endoscopic Resection of One of the Largest Tumors Reported to Date—A Case Report
Electrolyte depletion syndrome (EDS), also known as McKittrick–Wheelock syndrome, is a rare but life‐threatening condition caused by secretory diarrhea from colorectal villous tumors, often accompanied by severe electrolyte imbalances and renal dysfunction. Large, circumferential tumors have traditionally been managed with surgical resection, frequently requiring stoma formation. Recently, endoscopic submucosal dissection (ESD) has emerged as a minimally invasive alternative, although its feasibility for large rectal tumors remains limited. We report a case of EDS caused by a giant circumferential rectal villous tumor measuring approximately 28 cm, successfully treated with ESD. A 58‐year‐old man presented with persistent diarrhea, electrolyte disturbances, and acute kidney injury. Imaging and endoscopy revealed a circumferential villous tumor extending from the anal verge to the rectosigmoid colon, diagnosed as a villous adenoma without malignancy on biopsy. After careful discussion between the departments of gastrointestinal surgery and gastroenterology, ESD under general anesthesia was selected to avoid colectomy and stoma creation. En bloc resection of a 280 × 240 mm tumor was achieved without major complications. Prophylactic steroid injection and systemic steroid administration prevented post‐ESD stricture. Histopathology revealed adenocarcinoma with minimal submucosal invasion (800 µm), no lymphovascular invasion, and negative resection margins, indicating curative resection. At 6‐month follow‐up, no recurrence or stricture was observed. This case highlights the potential of ESD as a definitive and less invasive treatment option for EDS caused by large rectal villous tumors when performed with appropriate therapeutic planning and meticulous postoperative care.